Objective: To assess the role of matrix metalloproteinases (MMPs) in cartil
age and bone erosions in Lyme arthritis
Methods. We examined synovial fluid from 10 patients with Lyme arthritis fo
r the presence of MMP-2, MMP-3, MMP-9, and "aggrecanase" activity using gel
atinolytic zymography and immunoblot analysis. We developed an in vitro mod
el of Lyme arthritis using cartilage explants and observed changes in carti
lage degradation in the presence of Borrelia burgdorferi and/or various pro
tease inhibitors.
Results. Synovial fluid from patients with Lyme arthritis was found to cont
ain at least 3 MMPs: gelatinase A (MMP-2), stromelysin (MMP-3), and gelatin
ase B (MMP-9). In addition, there was evidence in 2 patients of "aggrecanas
e" activity not accounted for by the above enzymes. Infection of cartilage
explants with B burgdorferi resulted in induction of MMP-3, MMP-9, and "agg
recanase" activity. Increased induction of these enzymes by B burgdorferi a
lone was not sufficient to cause cartilage destruction in the explants as m
easured by glycosaminoglycan (GAG) and hydroxyproline release. However, add
ition of plasminogen, which can act as an MMP activator, to cultures result
ed in significant GAG and hydroxyproline release in the presence of B burgd
orferi. The MMP inhibitor batimastat significantly reduced the GAG release
and completely inhibited the collagen degradation.
Conclusion. MMPs are found in synovial fluids from patients with Lyme arthr
itis and are induced from cartilage tissue by the presence of B burgdorferi
. Inhibition of MMP activity prevents B burgdorferi-induced cartilage degra
dation in vitro.